Jason Efstathiou, MD, DPhil, discusses the utility of trimodal therapy in patients with muscle-invasive bladder cancer.
Jason Efstathiou, MD, DPhil
Advertisement
Articles by Jason Efstathiou, MD, DPhil
Jason Efstathiou, MD, DPhil, discusses the role of tri-modality therapy in patients with muscle-invasive bladder cancer.
The challenge of pelvic failure following contemporary cystectomy has been engaged and the clinical trials to pursue the amelioration of this problem have commenced.
Advertisement
Latest Updated Articles
Dr Efstathiou on the Role of Tri-Modality Therapy in MIBCPublished: March 15th 2024 | Updated:
Are Surgery and Chemotherapy Sufficient to Treat Locally Advanced Bladder Cancer?Published: October 11th 2015 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5